¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
4/22 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2023-04-21
Á¶È¸¼ö
136


¾È³çÇϼ¼¿ä.
À̹øÁÖ ¹ßÇ¥ÀÚ ¹Î¼ºÀÔ´Ï´Ù.

Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2019³â Immunity ¿¡ ÃâÆǵÈ
"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages" ÀÔ´Ï´Ù.

Host¿Í microbiomeÀÇ cross-talk´Â Àå³» Ç×»ó¼ºÀ» À¯ÁöÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù.

ÇÏÁö¸¸ ¹Ì»ý¹°ÀÇ dysbiosis¸¦ ÅëÇÑ maladaptationÀ̳ª AIEC¿Í °°Àº ħÀÔ¼º Àå³» ¼¼±Õ¿¡ ´ëÇÑ defense ´É·ÂÀÇ °áÇÔÀº chronicÇÑ Áúº´À» À¯µµÇÒ ¼ö ÀÖ´Ù°í ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.

À§ ³í¹®¿¡¼­´Â bacterial metaboliteÀÎ butyrateÀÇ ¿µÇâÀ» ¹Þ¾Æ ºÐÈ­µÈ macrophage°¡ Çâ»óµÈ antimicrobial activity¸¦ º¸Àδٴ °ÍÀ» º¸¿©ÁÖ¾ú½À´Ï´Ù.

ÀÚ¼¼ÇÑ ¸ÞÄ¿´ÏÁòÀ¸·Î´Â Butyrate¿¡ ÀÇÇØ À¯µµµÈ antimicrobial activity´Â macrophageÀÇ metabolismÀÇ º¯È­, mTOR kinase È°¼ºÀÇ °¨¼Ò, LC3 ¸Å°³ host defense ´É·Â Áõ°¡ ¹× anti-microbial peptideÀÇ »ý¼º°ú °ü·ÃÀÌ ÀÖ¾úÀ» ¹àÇû½À´Ï´Ù.

ÀÌ·¯ÇÑ °úÁ¤¿¡ À־ butyrate´Â histone deacetylase 3 (HDAC3) ¾ïÁ¦¸¦ ÅëÇØ monocyte¸¦ macrophage·Î ºÐÈ­Çϵµ·Ï À¯µµÇÏ¿´½À´Ï´Ù.

Áï, butyrateÀÇ Åõ¿©´Â »ýü ³» Àå³» macrophage¿¡¼­ anti-microbial activity¸¦ À¯µµÇÏ°í Àå³» º´¿øü¿¡ ´ëÇÑ resistance¸¦ Áõ°¡½ÃÅ´À» ¹àÇô³½ ³í¹®ÀÔ´Ï´Ù.


ÀúÀÇ ¿¬±¸¿¡¼­ ¸ðµç º¯È­ÀÇ ½ÃÀÛÀº antibiotics 󸮿¡ ÀÇÇØ ¹Ì»ý¹° ±ÕÃÑÀÇ º¯È­ ¹× ±×¿¡ µû¸¥ metabolite ƯÈ÷ SCFA°¡ º¯È­µÇ¾î À¯µµµÈ °ÍÀ¸·Î ¿¹»óµÇ±â¿¡ SCFA¿Í ÇÔ²² innate immunity¿¡ Áß¿äÇÑ macrophageÀÇ °ü°è¿¡ ´ëÇÑ °øºÎ¸¦ ¸ñÀûÀ¸·Î ¼±Á¤ÇÏ¿´½À´Ï´Ù..  

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.

°¨»çÇÕ´Ï´Ù.

¹Î¼º ¿Ã¸²

³í¹®»çÀÌÆ®: https://www.sciencedirect.com/science/article/pii/S1074761318305661?via%3Dihub
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
4/29 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ´ÙÁ¤ÀÔ´Ï´Ù. Á¦°¡ À̹ø¿¡ ¼±Á¤ÇÑ ³í¹®Àº2021³â Cellular & MolecularImmunology(IF:22.1)¿¡ÃâÆÇµÈ 'Enforced PGC-1a expression promotes CD8 T cell fitness, memory formation and antitumor immunity'ÀÔ´Ï´Ù. À§ ³í¹®Àº mitochondrial biogenesis¿¡ °ü¿©ÇÏ..
ÀÌÀü±Û
4/22 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº2022³â frontiers in immunology¿¡ ÃâÆÇµÈ "SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation" ÀÔ´Ï´Ù. ÀÌ ¿¬±¸¿¡¼­´Â COVID-19 °¨¿° ½Ã spike, nu..